TRT and Sleep: Apnea, Insomnia & Night Sweats in 2026

TRT and sleep in three numbers

Three numbers show why TRT and sleep need a closer look than most men give them.

Figures come from PubMed abstracts, the Endocrine Society guideline and the AndroGel 1.62% label. Where no study gives a number, we say so and mark the advice as a rule of thumb.

What this TRT and sleep guide covers

TRT and sleep: a two way street

Testosterone rises during sleep. A review found the rise depends on sleep itself, needing at least 3 hours of normal sleep, not just the time of day (PMID 24435056).

A meta analysis of 18 studies found that 24 hours or more without sleep lowered testosterone. Short partial sleep loss did not have a significant effect (PMID 34801825).

The other direction matters too. In a Japanese trial subanalysis, one year of TRT improved sleep disturbance in hypogonadal men without sleep apnea (PMID 28920756).

In a second subanalysis, six months of TRT improved nighttime urination and sleep scores in men with low testosterone and nocturia (PMID 26075538).

The same Japanese study suggested sleep disturbance may be a clinical sign of severe hypogonadism. Men with poor sleep scored worse on symptom, urinary, erection and quality of life scales (PMID 28920756).

So when TRT and sleep both improve together, it is often because the low testosterone itself was disturbing sleep.

TRT sleep apnea: what the trials found

TRT sleep apnea is the most important sleep issue on testosterone therapy. The gel label warns that testosterone may make it worse in some men, especially with obesity or chronic lung disease (AndroGel label).

In 17 healthy older men, high dose testosterone shortened sleep by about an hour. Breathing disturbances rose by about 7 events per hour (PMID 12915643).

Upper airway size did not change in that study, so the effect was not from a narrower throat. Sleepiness, mood and driving scores did not change either over the short trial (PMID 12915643).

In 67 obese men with severe apnea on a diet, testosterone worsened oxygen dips by 10.3 per hour at week 7 (PMID 22512435).

By week 18 the difference was 4.5 per hour and no longer significant. The authors called it mild and time limited (PMID 22512435).

A review concluded that, apart from a very transient effect, testosterone treatment does not adversely affect apnea at replacement doses (PMID 24435056).

The Endocrine Society recommends against starting testosterone in men with untreated severe obstructive sleep apnea (Endocrine Society guideline, PMID 29562364).

Who should be screened for TRT sleep apnea?

TRT and sleep problems overlap because sleep apnea is common in the same men who are most likely to have low testosterone. A 2023 review named male sex, older age, obesity and metabolic syndrome as the main risk factors for both (PMID 37881222).

Does treating apnea fix low testosterone? Not reliably. A review found CPAP for moderate to severe apnea did not reliably raise testosterone in most studies (PMID 24435056).

Weight loss did. The same review found testosterone rose predictably and linearly with the amount of weight lost (PMID 24435056).

The sleep apnea and hematocrit loop

TRT sleep apnea also matters for your blood count. Sleep apnea and testosterone can both push red blood cells up. A 2023 review noted that apnea has been proposed as a risk factor for secondary polycythemia, and that TRT might make it worse (PMID 37881222).

The same review said TRT is generally contraindicated by guidelines in untreated or severe apnea (PMID 37881222).

It also suggested that short high dose TRT might worsen apnea, while long term lower doses might eventually improve symptoms (PMID 37881222).

The Endocrine Society lists elevated hematocrit, like untreated severe apnea, as a reason not to start testosterone without further evaluation (Endocrine Society guideline, PMID 29562364).

Does TRT cause insomnia?

Sometimes, but TRT insomnia is uncommon at normal doses. The gel label lists insomnia among reactions reported by 2 percent or fewer patients in an open label period, and in postmarketing reports (AndroGel label).

The clearest signal of TRT insomnia comes from high doses. In the older men study, three weekly injections cut total sleep by about an hour (PMID 12915643).

A review noted that large doses and steroid abuse are linked to abnormal sleep duration and structure, unlike replacement doses (PMID 24435056).

The same review reported experimental data suggesting testosterone may change how strongly men feel the effects of short sleep (PMID 24435056). TRT insomnia is not the whole story.

Rule of thumb: a steady level is kinder to sleep than big swings. Talk to your prescriber before changing dose or timing.

TRT night sweats: normal or a red flag?

TRT night sweats are reported, but they are not well studied. The gel label lists sweating and hot flushes only among postmarketing reports, without percentages (AndroGel label).

No trial we found measured night sweats as an outcome on TRT. So timelines you read online are rule of thumb.

How to protect sleep on TRT

These steps for TRT and sleep follow the evidence above. The first three are checks, the rest are habits.

1. Screen for apnea before starting. The guideline advises against starting TRT in untreated severe apnea (Endocrine Society guideline, PMID 29562364).

2. Avoid high doses and big peaks. High doses cut sleep and worsened breathing (PMID 12915643).

3. Recheck if symptoms appear early. Apnea worsening was strongest at week 7 in one trial (PMID 22512435).

4. Protect total sleep. Full nights matter: 24 hours without sleep lowered testosterone (PMID 34801825).

5. Lose weight if needed. A review found weight loss raises testosterone predictably, in proportion to the weight lost (PMID 24435056).

6. Keep a two week sleep log. Rule of thumb: note bedtime, wake time, snoring reports, night sweats and dose days. Patterns show up fast and make the conversation with your prescriber useful.

7. Limit late caffeine and alcohol. Rule of thumb: both disturb sleep on their own, and they can be mistaken for TRT insomnia.